Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dau-Ming Niu

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Diagnostics (Basel, Switzerland)|January 26, 2020
Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with MucopolysaccharidosesHsiang-Yu Lin, Chih-Kuang Chuang, Chung-Lin Lee, et al.
The Canadian Journal of Cardiology|February 28, 2016
Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement TherapyKuan-Hsuan Chen, Yueh Chien, Kang-Ling Wang, et al.
Orphanet Journal of Rare Diseases|June 20, 2022
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registryMichael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.
American Journal of Medical Genetics. Part A|April 28, 2009
Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004Hsiang-Yu Lin, Shuan-Pei Lin, Chih-Kuang Chuang, et al.
Orphanet Journal of Rare Diseases|July 23, 2014
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)Hao-Chuan Liu, Hsiang-Yu Lin, Chia-Feng Yang, et al.
The Journal of Pediatrics|December 20, 2015
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better OutcomesChia-Feng Yang, Chen Chang Yang, Hsuan-Chieh Liao, et al.
Clinical Kidney Journal|January 4, 2021
Fabry disease and COVID-19: international expert recommendations for management based on real-world experienceDawn A Laney, Dominique P Germain, João Paulo Oliveira, et al.
Pediatric Transplantation|January 17, 2022
Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patientsNiang-Cheng Lin, Hsin-Lin Tsai, Cheng-Yen Chen, et al.
Diagnostics (Basel, Switzerland)|October 9, 2019
An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in TaiwanHsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, et al.
American Journal of Medical Genetics. Part A|November 19, 2013
A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatmentChia-Feng Yang, Hao-Chuan Liu, Ting-Rong Hsu, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Diagnostics (Basel, Switzerland)|January 26, 2020
Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with MucopolysaccharidosesHsiang-Yu Lin, Chih-Kuang Chuang, Chung-Lin Lee, et al.
The Canadian Journal of Cardiology|February 28, 2016
Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement TherapyKuan-Hsuan Chen, Yueh Chien, Kang-Ling Wang, et al.
Orphanet Journal of Rare Diseases|June 20, 2022
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registryMichael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.
American Journal of Medical Genetics. Part A|April 28, 2009
Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004Hsiang-Yu Lin, Shuan-Pei Lin, Chih-Kuang Chuang, et al.
Orphanet Journal of Rare Diseases|July 23, 2014
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)Hao-Chuan Liu, Hsiang-Yu Lin, Chia-Feng Yang, et al.
The Journal of Pediatrics|December 20, 2015
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better OutcomesChia-Feng Yang, Chen Chang Yang, Hsuan-Chieh Liao, et al.
Clinical Kidney Journal|January 4, 2021
Fabry disease and COVID-19: international expert recommendations for management based on real-world experienceDawn A Laney, Dominique P Germain, João Paulo Oliveira, et al.
Pediatric Transplantation|January 17, 2022
Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patientsNiang-Cheng Lin, Hsin-Lin Tsai, Cheng-Yen Chen, et al.
Diagnostics (Basel, Switzerland)|October 9, 2019
An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in TaiwanHsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, et al.
American Journal of Medical Genetics. Part A|November 19, 2013
A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatmentChia-Feng Yang, Hao-Chuan Liu, Ting-Rong Hsu, et al.
Pageof 19